Methods for treating interleukin-6 related diseases

Assignee: Chugai Seiyaku Kabushiki Kaisha

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 7,521,052
App. No.: 10/554,407
Granted: Apr 21, 2009
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).

Claims (1)

1. A method for treating rheumatoid arthritis, comprising administering an effective amount of an anti-IL-6 receptor antibody (anti-IL-6R antibody) and an effective amount of methotrexate (MTX) to a patient in need thereof, wherein the anti-IL-6R antibody is a humanized PM-1 antibody.

Assignments (1)

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2005

From: OKUDA, OSAMU; YOSHIDA, NORIAKI; MAINI, RAVINDER NATH

To: CHUGAI SEIYAKU KABUSHIKI KAISHA

Reel/Frame 017904/0579 →

Priority Claims (1)

GB 0309619.5 · Apr 28, 2003 · national

Continuity (1)

Related Publication 20060251653A1 · Nov 9, 2006